Korro Bio IPO

korrobio.com

Korro Bio is a biotechnology company specializing in gene therapy whose RNA editing approach leverages already natural occurring processes.

Founded2018
Total Funding to Date$197.87MM
Register for Details

For more details on financing and valuation for Korro Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Korro Bio Ticker Symbol

Korro Bio does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Korro Bio Stock Price

The stock price for Korro Bio will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Korro Bio Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/5/2022 Series B-1 and B-2 $290.4MM $XXX.XX $XXX.XX
9/10/2020 Series A $174.81MM $XXX.XX $XXX.XX
12/31/2019 Series Seed 3 $29.86MM $XXX.XX $XXX.XX
5/24/2019 Series Seed 1 and Seed 2 $12MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Korro Bio in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM